Connection

Yusuf Hannun to Recurrence

Back to Details
This is a "connection" page, showing publications Yusuf Hannun has written about Recurrence.
Yusuf Hannun
Connection Strength
0.019
Recurrence
  1. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15; 17(18):6097-105.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.